Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Petra Kaufmann*, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen-Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman-PattersonEdward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto, Bruce Levin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III'. Together they form a unique fingerprint.

Medicine & Life Sciences